* LeMaitre Vascular Inc LMAT.OQ LMAT.O is expected
to show a
rise in quarterly revenue when it reports results on April 28.
* The Burlington Massachusetts-based company is expected to
report a 7.7% increase in revenue to $38.653 million from
$35.88 million a year ago, according to the mean estimate from 8
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for LeMaitre Vascular
Inc is
for earnings of 28 cents per share. For the same quarter last
year, the company reported earnings of 28 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts had fallen by
about 0.8%
in the last three months.
* Wall Street's median 12-month price target for LeMaitre
Vascular
Inc is $65, above its last closing price of $44.41.
* Previous quarterly performance (using preferred earnings
measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Dec. 31 2021 0.31 0.31 0.28 Missed -8.6
Sep. 30 2021 0.33 0.33 0.30 Missed -7.7
Jun. 30 2021 0.35 0.34 0.40 Beat 18.2
Mar. 31 2021 0.27 0.27 0.28 Beat 3.1
Dec. 0.30 0.29 0.34 Beat 15.9
31 2020
Sep. 30 2020 0.20 0.19 0.37 Beat 90.7
Jun. 30 2020 0.00 0.01 0.21 Beat 3,048.
4
Mar. 31 2020 0.16 0.15 0.16 Beat 4.4
This summary was machine generated April 27 at 02:02 GMT. All
figures in US dollars unless otherwise stated